Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

the experimental drug retatrutide (Eli Lilly and Company) produces the greatest weight loss. The review, conducted by researchers at McGill University, Montreal, Quebec, Canada, examined three ...

The analysis found that retatrutide caused the greatest weight loss — participants lost up to 22.1% of their weight after 48 weeks versus people who took a placebo. Eli Lilly’s retatrutide is ...

I recently learned of Eli Lilly ... of Indiana (note: Lilly is headquartered in Indianapolis), challenges FDA’s decision to regulate Lilly’s trial product “retatrutide” as a drug rather ...

Retatrutide, Eli Lilly's drug candidate under development, showed around a 20% placebo-corrected weight loss at a similar stage in its trial but was tested in heavier patients. Novo Nordisk's ...

Adding to the competitive landscape, Bloomberg Intelligence analyst Michael Shah noted the significance of the new data, stating, "cross-trial comparisons suggesting better efficacy than Eli Lilly's ...